Metastatic colorectal cancer vaccine
AssigneeThomas Jefferson University
InventorScott A. Waldman
Life of this patent
Estimating the term…
Abstract
The invention relates to prophylactic and therapeutic vaccines for protecting individuals against metastatic colorectal cancer and for treating individuals who are suffering from metastatic colorectal cancer.
Claims9
A method of treating an individual who has metastasized colorectal cancer comprising the step of administering to such an individual a therapeutically effective amount of an expression vector comprising a nucleic acid molecule that encodes SEQ ID NO:2 or a fragment thereof comprising amino acids 24-454 of SEQ ID NO:2.
A method of treating an individual who has been identified as being susceptible to metastasized colorectal cancer comprising the step of administering to such an individual a prophylactically effective amount of an expression vector comprising a nucleic acid molecule that encodes SEQ ID NO:2 or a fragment thereof comprising amino acids 24-454 of SEQ ID NO:2.
Dependencies are inferred from the claim text.